
HCA
HCA Holdings, Inc. (HCA) is one of the largest private operators of hospitals and outpatient facilities in the United States. The company earns revenue from inpatient and outpatient care, surgeries, emergency services and ancillary diagnostics across a broad network of acute-care hospitals and ambulatory centres. Scale provides negotiating power with payors and some operational efficiencies, but the business is capital intensive and sensitive to labour costs, regulation and reimbursement changes from Medicare, Medicaid and private insurers. HCA’s performance also ties to volumes for elective procedures and broader economic conditions. Investors often watch occupancy trends, payer mix, margins and leverage when assessing prospects. With a market capitalisation around $101 billion, HCA combines steady demand driven by an ageing population with exposure to regulatory and cost pressures. This is general educational information, not advice; values can fall as well as rise and suitability depends on individual circumstances.
Why It's Moving

HCA faces fresh downside chatter as analysts weigh solid operating execution against a now-stretched valuation backdrop.
- Recent analyst commentary has emphasized that HCA’s shares are trading near levels that already price in strong performance, making the stock more vulnerable if results merely meet expectations rather than beat them.
- At the same time, analysts have pointed to HCA’s steady operational momentum and guidance execution as reasons the business remains fundamentally sound, which helps explain why the stock has not broken down despite the cautionary tone.
- The broader message from Wall Street is mixed: optimism about HCA’s defensive healthcare exposure and earnings quality is being offset by concerns that valuation has outrun short-term catalysts, creating a tighter risk-reward setup.

HCA faces fresh downside chatter as analysts weigh solid operating execution against a now-stretched valuation backdrop.
- Recent analyst commentary has emphasized that HCA’s shares are trading near levels that already price in strong performance, making the stock more vulnerable if results merely meet expectations rather than beat them.
- At the same time, analysts have pointed to HCA’s steady operational momentum and guidance execution as reasons the business remains fundamentally sound, which helps explain why the stock has not broken down despite the cautionary tone.
- The broader message from Wall Street is mixed: optimism about HCA’s defensive healthcare exposure and earnings quality is being offset by concerns that valuation has outrun short-term catalysts, creating a tighter risk-reward setup.
When is the next earnings date for HCA (HCA)?
HCA Healthcare's next earnings date is estimated between July 23 and July 27, 2026, following the recent Q1 2026 release on April 24, 2026. This announcement will cover results for the second quarter of 2026 (Q2 2026), aligning with the company's historical quarterly reporting pattern. No official date has been confirmed yet by the company.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying HCA's stock, expecting it to rise towards the target price of $481.68.
Financial Health
HCA is performing strongly with substantial revenue, profits, and cash flow, indicating strong financial health.
Dividend
HCA's low dividend yield of 0.69% indicates limited returns for dividend-seeking investors. If you invested $1000 you would be paid $6.90 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
CVS
CVS Health is a healthcare company that provides pharmacy, health insurance, and other healthcare services.
ELEVANCE HEALTH INC
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
Cigna Corp
Cigna is a global health service company providing health insurance and related services
Baskets Featuring HCA
Government Shutdown Impact: Defensive Stocks Explained
A U.S. government shutdown has been triggered by a congressional budget impasse, creating economic uncertainty. This theme focuses on companies in defensive sectors that may prove resilient to the resulting market volatility and disruptions in federal spending.
Published: October 2, 2025
Explore BasketWalgreens Restructuring Explained: Investment Shifts
Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.
Published: September 2, 2025
Explore BasketDefensive Plays Amid Fed Turmoil
The removal of a Federal Reserve governor has created political and financial uncertainty, shaking confidence in the central bank's stability. This environment could create opportunities for investments in defensive sectors and assets that are traditionally seen as safe havens during periods of market volatility.
Published: August 26, 2025
Explore BasketFollowing Buffett's Healthcare Bet
Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.
Published: August 15, 2025
Explore BasketHealthcare In The Crosshairs: Insurers Under Scrutiny
The Department of Justice is investigating UnitedHealth Group's Medicare billing, creating uncertainty for the nation's largest insurer. This situation presents a potential opportunity for rival health insurers to gain market share and for compliance-focused companies that help the industry navigate complex regulations.
Published: July 25, 2025
Explore BasketRiding The Regulatory Wave In Healthcare
The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.
Published: July 25, 2025
Explore BasketSenior Living Shakeout: Leaders After Genesis
This carefully selected group of stocks represents companies positioned to thrive following Genesis HealthCare's bankruptcy. Handpicked by our analysts, these healthcare providers and REITs stand to gain significant market share as the senior care industry undergoes a major transformation.
Published: July 11, 2025
Explore BasketHealthcare Billing Integrity
This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.
Published: July 11, 2025
Explore BasketMedicaid Politics
Discover companies whose fortunes are closely tied to government healthcare funding decisions. These carefully selected stocks represent businesses with significant exposure to Medicaid, now facing heightened legislative uncertainty after Senator Tillis's retirement.
Published: June 30, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Large Hospital Network
HCA’s national footprint offers scale advantages in purchasing and revenue diversification, though local market dynamics and competition can influence performance.
Demographic Tailwinds
An ageing population supports demand for healthcare services over the long term, but funding and reimbursement policies remain important uncertainties.
Operational Efficiency Focus
Management emphasises cost control and outpatient expansion to improve margins, yet labour costs and capital expenditure needs can pressure cash flow.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.